Get started
RocketTickers

NuCana Announces FDA Clearance to Commence Phase III Study of Ac

Long
NuCana plc (NASDAQ:NCNA)  
RocketTickers  
NASDAQ:NCNA   NuCana plc
Beyond Technical Analysis
1
0
beyondta
NCNA: NuCana plc
2019-10-25 07:00:05
NuCana Announces FDA Clearance to Commence Phase III Study of Acelarin (NUC-1031) for the First-Line Treatment of Patients with Biliary Tract Cancer

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.